Home » Home » Further updates

Updates

Previous updates to Tobacco in Australia: Facts & issues

Section 13.6 Revenue from tobacco taxes in Australia, updated May 2023
Section 6.13 Addiction and the adolescent smoker, updated May 2023
Section 1.6 Prevalence of smoking—teenagers, updated May 2023
Section 18.3 Prevalence of e-cigarette use, updated May 2023
Section 11.9 Retail promotion and access, updated May 2023
Tobacco in Australia: Facts & Issues EndNote library of chapters and sections citations, updated May 2023
Section 11.7 Promotional events, updated May 2023
Section 18.5 Chemicals in e-liquids and e-cigarette aerosols, updated May 2023
Section 11A.6 International flow-on effects, updated April 2023
Section 11.8 Trade promotions, updated April 2023
Section 12.7 Menthol, updated April 2023
Section 9.0 Introduction, updated April 2023
Tobacco in Australia: Facts & Issues EndNote library of chapters and sections citations, updated April 2023
Section 5.30 Harnessing predictors of uptake to prevent smoking, updated April 2023
Section 5.24 The profound effects of the denormalisation of smoking, updated April 2023
Section 13.2 Tobacco taxes in Australia, updated April 2023
Section 2.4 Expenditure on tobacco products, updated April 2023
Section 5.29 School-based interventions, updated April 2023
Section 10A.7 Mechanisms of influence—political lobbying, updated March 2023
Section 9.7 Explanations of socio-economic disparities in smoking, updated March 2023
Section 7.21 Lung cancer screening and biomedical risk assessments, updated March 2023
Section 7.16 Pharmacotherapies for smoking cessation, updated March 2023
Section 2.5 Industry sales figures as estimates for consumption, updated March 2023
Chapter 19: FCTC, updated March 2023
Tobacco in Australia: Facts & Issues EndNote library of chapters and sections citations, updated February 2023
Chapter 18: E-cigarettes and other alternative nicotine products, updated February 2023
- 18.1 The e-cigarette market
- 18.4.3 Environmental impact
- 18.6 The health effects of e-cigarette use
  - 18.6.1 Health effects of e-cigarette use during pregnancy
  - 18.6.5 E-cigarette use and the risk of non-infectious respiratory diseases
  - 18.6.6 E-cigarette use and the risk of infectious diseases
  - 18.6.7 E-cigarette use and oral health
  - 18.6.9 Exposure to secondhand e-cigarette emissions
- 18.12 Public perceptions of the risks and benefits of e-cigarettes
Section 18A.5 Regulating sale and promotion of smokeless tobacco, updated February 2023
Section 3.5 Other cancers, updated February 2023
Section 7.18 Alternative therapies and emerging treatments, updated January 2023
Section 7.13 Cessation assistance: printed self-help materials, updated January 2023
Section 7.5 What we know about how smokers are persuaded to attempt to quit, updated January 2023
Section 7.11 Smoking cessation and pregnancy, updated January 2023
Section 10.7 Market share and brand share in Australia, updated December 2022
Section 5.28 Peer-based approaches, updated December 2022
Section 3.36, updated December 2022
Section 18B.3 Prevalence of e-cigarette use, updated November 2022
Section 9A.7 Military personnel and veterans, updated November 2022
Section 9.7 Explanations of socio-economic disparities in smoking, updated November 2022
Section 9.5 Smoking and intergenerational poverty, updated November 2022
Section 5.27 Family and home-based interventions to reduce smoking uptake, updated November 2022
Section 18.3 Prevalence of e-cigarette use, updated October 2022
Section 13.6 Revenue from tobacco taxes in Australia, updated October 2022
Section 18.14 E-cigarettes international regulatory overview, updated October 2022
Section 18.13 E-cigarettes legal status in Australia, updated October 2022
Section 11B Licensing of tobacco sellers, updated October 2022
Section 1.6 Prevalence of smoking—teenagers, updated October 2022
Section 7.6 How smokers go about quitting, updated October 2022
Section 5.25 Media campaigns and young people, updated October 2022
Section 13.6 Revenue from tobacco taxes in Australia, updated October 2022
Section 11A.6 International flow-on effects, updated October 2022
Section 11A.9 Real-world research on the effects of plain packaging, updated October 2022
Section 13.2 Tobacco taxes in Australia, updated September 2022
Section 7.19 Interventions tailored for age and/or gender, updated September 2022
Section 7.10 Role of health professionals and social services, updated September 2022
Section 18.5 Chemicals in e-liquids and e-cigarette aerosols, published August 2022
Section 7.14 Cessation assistance: telephone- and internet-based interventions, updated August 2022
Section 9.4 The relationship between tobacco smoking and financial stress, updated August 2022
Section 10.18 The investment of public funds in tobacco - the case for divestment, updated August 2022
Section 7.7 Environmental and biopsychosocial factors that influence quitting, updated August 2022
Section 7.9 Increasing smoking cessation at the population level, updated August 2022
Chapter 12 Tobacco products, updated August 2022
- Section 12.0 Introduction
- Section 12.1 Tobacco in cigarettes
- Section 12.2 Other types of tobacco products
- Section 12.3 Chemicals and contaminants in tobacco products
- Section 12.4 Emissions from tobacco products
- Section 12.5 Measuring emissions and exposure to tobacco products
- Section 12.6 Additives and flavourings in tobacco products
- Section 12.7 Menthol
- Section 12.8 Construction of cigarettes and cigarette filters
- Section 12.9 Labelling of tobacco products in Australia
Section 7.11 Smoking cessation and pregnancy, updated August 2022
Section 18.7 Effects of e-cigarette use on smoking, updated August 2022
Chapter 8 Tobacco use among Aboriginal and Torres Strait Islander peoples, updated July 2022
- Section 8.1 Aboriginal and Torres Strait Islander peoples: social disadvantage, health and smoking—an overview
- Section 8.5 Types of tobacco used by and levels of consumption among Aboriginal and Torres Strait Islander peoples
- Section 8.7 Morbidity and mortality caused by smoking among Aboriginal and Torres Strait Islander peoples
- Section 8.10 Tobacco action initiatives targeting Aboriginal and Torres Straits Islander peoples
- Section 8.14 The effectiveness of population-level tobacco control strategies
- Section 8.15 The role of health workers and community organisations
Section 9.6 Tailored and targeted interventions for low socioeconomic groups, updated July 2022
InDepth 9A Addressing smoking in highly disadvantaged and other priority groups, added July 2022:
- Section 9A.1 People living in regional and remote areas of Australia
- Section 9A.2 Culturally and linguistically diverse groups
- Section 9A.3 People with substance use and mental disorders
- Section 9A.4 People experiencing homelessness
- Section 9A.5 People experiencing incarceration
- Section 9A.6 Lesbian, gay, bisexual, trans, queer and intersex (LGBTQI+) people
- Section 9A.7 Military personnel and veterans
- Section 9A.8 Single parents
Section 4.16 Secondhand smoke and pregnancy, updated June 2022
Section 13.3 The price of tobacco products in Australia, updated June 2022
Section 18B.3 Prevalence of e-cigarette use, updated June 2022
Section 5.16 Smoking in movies, TV and other popular culture/media, updated April 2022
Section 3.9 Increased susceptibility to infection in smokers, updated April 2022
Section 5.13.3 Products and packaging created to appeal to new users, updated April 2022
Section 15.6 Smoking bans in the home and car, updated April 2022
Section 18B.10 Key Australian and international position statements on e-cigarettes, health, and options for regulation, updated April 2022
Section 14.3 Public education campaigns to discourage smoking: the Australian experience, updated April 2022
Section 1.10 Prevalence of smoking in other high-risk sub-groups of the population, updated March 2022
Section 18B.3 Prevalence of e-cigarette use, updated March 2022
Section 11A.6 International flow-on effects, updated March 2022
Section 9.8 Are current strategies to discourage smoking in Australia inequitable?, updated March 2022
Section 2.4 Expenditure on tobacco products, updated March 2022
Appendix 1.16 Public perceptions of tobacco as a drug, and public opinion regarding tobacco control policies, updated March 2022
Section 9.9 Are there inequalities in access to and use of treatment for dependence on tobacco-delivered nicotine?, updated March 2022
Section 9.3 Contribution of smoking to health inequality, updated March 2022
Section 10.14 Ethical issues related to tobacco farming and production, updated March 2022
Section 18B.14 Policies and programs to reduce e-cigarette use among young people and non-smokers, updated February 2022
Section 18.4 Reducing the nicotine content of cigarettes, updated February 2022
Section 2.5 Industry sales figures as estimates for consumption, updated February 2022
Section 10A.7 Mechanisms of influence—political lobbying, updated February 2022
Section 13.0 Introduction to the pricing and taxation of tobacco products in Australia, updated January 2022
Section 13.2 Tobacco taxes in Australia, updated January 2022
Section 13.3 The price of tobacco products in Australia, updated January 2022
Section 13.10 Arguments against tax increases promoted by the tobacco industry, updated January 2022
Appendix 1.15 Understanding the tobacco industry, updated January 2022
Section 1.3 Prevalence of smoking—adults, updated December 2021
Section 18B.7 Population-level benefits and harms of increasing e-cigarette use, updated December 2021
Section 18B.6 Effects of e-cigarette use on smoking, updated December 2021
Section 17.2 The costs and benefits of smoking to the Australian economy, updated December 2021
Section 1.4 Prevalence of smoking—young adults, updated December 2021
Section 1.5 Prevalence of smoking—middle-aged and older adults, updated December 2021
Section 3.30 Total burden of death and disease attributable to tobacco by disease category, updated December 2021
Section 18B.3 Prevalence of e-cigarette use, updated December 2021
Section 15.7 Legislation to ban smoking in public spaces, updated November 2021
Section 18B.13 Cessation interventions for e-cigarette users, updated November 2021
Section InDepth 11B: Licensing of tobacco sellers, updated November 2021
Section 11.9 Retail promotion and access, updated November 2021
Section 10.16 The environmental impact of tobacco use, updated November 2021
Section 13.6 Revenue from tobacco taxes in Australia, updated October 2021
Section 1.10 Prevalence of smoking in other high-risk sub-groups of the population, updated October 2021
Section 7.19 Interventions for particular groups, updated October 2021
Section 18B.8 Legal status in Australia, updated October 2021
Section 15.7 Legislation to ban smoking in public spaces, updated October 2021
Section 9.2 Trends over time in smoking among priority populations in Australia, updated October 2021
Section 7.11 Smoking cessation and pregnancy, updated September 2021
Section 8.4 Smoking among Aboriginal and Torres Strait Islander children and teenagers, updated September 2021
Section 10.15 The environmental impact of tobacco production, updated September 2021
Section 9.6 Smoking, ill health, financial stress and smoking-related poverty among highly disadvantaged groups, updated September 2021
Section 8.3 Prevalence of tobacco use among Aboriginal peoples and Torres Strait Islanders, updated September 2021
Section 9.1 Socio-economic position and disparities in tobacco exposure and use, updated September 2021
Section 19.0 Background to the WHO Framework Convention on Tobacco Control, updated September 2021
Section 19.1 WHO FCTC Governance Framework, updated September 2021
Section 19.2 Implications of the WHO FCTC for Australia, updated September 2021
Section 19.4 Obligations relating to demand reduction for tobacco products, updated September 2021
Section 19.5 Obligations relating to supply-reduction for tobacco products, updated September 2021
Section 19.7 Obligations regarding international cooperation and exchange of information and resources, updated September 2021
Section 19.8 Enforcement of the WHO FCTC, updated September 2021
Section 19.9 Impact of the WHO FCTC and role in the context of global governance, updated September 2021
Section 17.2 The costs and benefits of smoking to the Australian economy, updated September 2021
Section 13.2 Tobacco taxes in Australia, updated September 2021
Section 18.3 Smoking reduction, updated September 2021
Section 3.8 Child health and maternal smoking before and after birth, updated September 2021
Section 3.7 Pregnancy and smoking, updated September 2021
Section 11A.6 International flow-on effects, updated September 2021
Section 13.3 The price of tobacco products in Australia, updated August 2021
Section 3.11 Dental diseases, updated August 2021
Section 3.1 Smoking and cardiovascular disease, updated August 2021
Section 16.5 Legal cases initiated by tobacco industry, updated August 2021
Section 18B.12 Influences on the uptake of e-cigarettes, updated August 2021
Section 4.10 Cancers of other sites,updated July 2021
Section 3.9 Increased susceptibility to infection in smokers, updated July 2021
Section 11A.6 International flow-on effects, updated July 2021
Section 3.21 Health effects of young people who smoke, updated July 2021
Section 18B.2 Electronic cigarettes: Advertising and promotion, updated July 2021
Section 2.4 Expenditure on tobacco products, updated June 2021
Section 13.3 The price of tobacco products in Australia, updated June 2021
Section 3.23 Smoking, dementia and cognition, updated June 2021
Section 3.22 Poorer quality of life and loss of function, updated June 2021
Section 10.7 Market share and brand share in Australia, updated June 2021
Section 3.15 The impact of smoking on treatment of disease, updated June 2021
Section 3.14 Skin, updated June 2021
Section 3.4 Lung cancer, updated June 2021
Section 3.5 Other cancers, updated June 2021
Section 3.13 Musculoskeletal diseases, updated June 2021
Section 3.27 Health effects of smoking tobacco in other forms, updated May 2021
Section 3.8 Child health and maternal smoking before and after birth, updated May 2021
Section 3.9 Increased susceptibility to infection in smokers, updated May 2021
Section 3.7 Pregnancy and smoking, updated May 2021
Section 7.17 Contingency management/incentives, updated May 2021
Section 12.8 Menthol and confectionery/liqueur flavoured cigarettes, updated May 2021
Section 3.12 Gastro-intestinal diseases, updated May 2021
Section 14.3 Public education campaigns to discourage smoking: the Australian experience, updated May 2021
Section 13.6 Revenue from tobacco taxes in Australia, updated May 2021
Section 7.16 Pharmacotherapies, updated May 2021
Section 3.4 Lung cancer, updated May 2021
Section 3.5 Other cancers, updated May 2021
Section 3.18 Other conditions with possible links to smoking, updated May 2021
Section 2.3 Self-reported measures of tobacco consumption, updated May 2021
Section 6.8 Interactions between tobacco smoke and medications, updated May 2021
Section 11A.6 Packaging as promotion; International flow-on effects, updated April 2021
Section 18B.3 Electronic cigarettes; Extent of use, updated April 2021
Section 2.0, Introduction: Trends in tobacco consumption in Tobacco, updated March 2021
Section 2.5, Industry sales figures as estimates for consumption, updated March 2021
Section 11A6, International flow-on effects, updated March 2021
Section 4.17, Health effects of secondhand smoke for infants and children, updated March 2021
Section 3.28 Health 'benefits' of smoking?, updated March 2021
Section 10.6 Retail value and volume of the Australian tobacco market, updated March 2021
Section 1.13 Smoking by Australian states and territories, updated March 2021
Section 1.10 Prevalence of smoking in other high-risk sub-groups of the population, updated March 2021
Section 1.12 Prevalence of use of different types of tobacco product, updated March 2021
Section 13.2 Tobacco taxes in Australia, updated March 2021
Section 13.10 Arguments against tax increases promoted by the tobacco industry, updated March 2021
Section 3.9.12 Coronaviruses and the COVID-19 pandemic, updated March 2021
Section 1.5 Prevalence of smoking—middle-aged and older adults, updated February 2021
Section 1.7 Trends in the prevalence of smoking by socio-economic status, updated February 2021
Section 1.8 Trends in prevalence of smoking by country of birth, updated February 2021
Section 3.25 Smoking compared with or in combination with other pollutants, updated February 2021
Section 4.5 Prevalence of exposure to secondhand smoke in the home, updated February 2021
Section 1.3 Prevalence of smoking—adults, updated February 2021
Section 1.4 Prevalence of smoking—young adults, updated February 2021
Section 18.3 Smoking reduction, updated February 2021
Section 4.5 Prevalence of exposure to secondhand smoke in the home, updated February 2021
Section 11.9 Retail promotion and access, updated February 2021
Section 3.24 Genetic influences on tobacco-caused disease, updated February 2021
Section 3.2 Respiratory diseases (excluding lung cancer), updated December 2020
Section 3.1 Smoking and cardiovascular disease, updated December 2020
Section 3.9 Increased susceptibility to infection in smokers, updated December 2020
Section 3.5 Other cancers, updated November 2020
Section 3.27 Health effects of smoking tobacco in other forms, updated November 2020
Section 5.10 Cultural background, updated November 2020
Section 5.8 The smoking behaviour of peers, and peer attitudes and norms, updated November 2020
Section 5.18 Uptake: a concluding note, updated November 2020
Chapter 19 FCTC, updated October 2020
Section 13.0 Introduction - The pricing and taxation of tobacco products in Australia, updated September 2020
Section 5.21 Reducing tobacco access and supply, updated September 2020
Section 5.17 Factors influencing uptake of smoking later in life, updated September 2020
Section 13.4 The affordability of tobacco products, updated August 2020
Section 18B.10 Key Australian and international position statements on e-cigarettes, health, and options for regulation, updated August 2020
Section 3.13 Musculoskeletal diseases, updated August 2020
Section 9.6 Smoking, ill health, financial stress and smoking-related poverty among highly disadvantaged groups, updated August 2020
Section 1.13 Smoking by Australian states and territories, updated August 2020
Section 13.2 Tobacco taxes in Australia, updated August 2020
Section 13.3 The price of tobacco products in Australia, updated August 2020
Section 3.32 Health effects of smoking other substances, updated August 2020
Section 10.5 Retailing of tobacco products in Australia, updated August 2020
Section 3.9 Increased susceptibility to infection in smokers, updated August 2020
Section 7.7 Factors that predict success or failure in quit attempts, updated August 2020
Section 7.12 Smoking and mental health, updated August 2020
Section 7.19 Interventions for particular groups, updated August 2020
Section 7.6 How smokers go about quitting, updated August 2020
Section 7.4 What finally prompts smokers to attempt to quit?, updated August 2020
Section 7.2 Quitting activity, updated August 2020
Section 1.2 Overview of major Australian data sets, updated August 2020
Section 1.13 Smoking by Australian states and territories, updated August 2020
Section 1.7 Trends in the prevalence of smoking by socio-economic status
Section 1.12 Prevalence of use of different types of tobacco product, updated August 2020
Section 18A.5 Regulating sale and promotion of smokeless tobacco, other jurisdictions, updated July 2020
Section 3.34 Public perceptions of tobacco as a drug, updated July 2020
Section 1.10 Prevalence of smoking in other high-risk sub-groups of the population, updated July 2020
Section 1.8 Trends in prevalence of smoking by country of birth, updated July 2020
Section 1.5 Prevalence of smoking - middle-aged and older adults, updated July 2020
Section 1.4 Prevalence of smoking - young adults, updated July 2020
Section 1.3 Prevalence of smoking - adults, updated July 2020
Section 18B.3 E-cigarettes; Extent of use, updated July 2020
Section 11.9.9 Public support for reducing retail promotion and access, updated July 2020
Section 10.17 Public attitudes to the tobacco industry, updated July 2020
Section 18A.2 Prevalence of use of smokeless tobacco in Australia, updated July 2020
Section 5.31 Uptake and Prevention: Other drug use, updated July 2020
Section 5.17 Factors influencing uptake of smoking later in life, updated July 2020
Section 3.31 Morbidity and mortality due to tobacco-caused disease and socio-economic disadvantage, updated July 2020
Section 2.4 Expenditure on tobacco products, updates July 2020
Section 3.9.11 Coronaviruses and the COVID-19 pandemic, updated July 2020
Section 13.3 The price of tobacco products in Australia, Figure 13.3.4, updated July 2020
Section 3.23 Smoking, dementia and cognition, updated July 2020
Section 3.17 Inflammatory conditions and autoimmune disease, updated June 2020
Section 3.5 Other cancers, updated June 2020
Section 3.22 Poorer quality of life and loss of function, updated June 2020
Section 3.16 Smoking and diabetes, updated June 2020
Section 3.9.11.2 COVID-19 pandemic, updated June 2020
Section 1.10, Fig1.10.1 Prevalence of smoking during any stage of pregnancy, updated June 2020
Section 3.14 Effects of smoking on the skin, updated June 2020
Section 3.10 Eye diseases, updated May 2020
Section 3.11 Dental diseases, updated May 2020
Section 3.19 Smoking and accidents, updated May 2020
Section 5.15 Tobacco advertising and promotion targeted at young people: updated May 2020
Section 18B.3 Extent of use: updated May 2020
Section 3.12 Gastro-intestinal diseases: updated May 2020
Section 3.3 Smoking and cancer: updated May 2020
Section 3.9 Increased susceptibility to infection in smokers: updated May 2020
Section 3.4 Lung cancer: updated May 2020
Section 3.20 Nicotine and carbon monoxide poisoning: updated May 2020
Section 18B.6 Potential negative impacts of e-cigarettes: updated May 2020
Section 18B.7 Potential positive impacts of e-cigarettes: updated April 2020
Chapter 19 The WHO Framework Convention on Tobacco Control: updated April 2020
Section 5.14 Opportunity to smoke: updated April 2020
Section 3.15 The impact of smoking on treatment of disease: updated April 2020
Section 18B.2 Advertising and promotion of e-cigarettes: updated April 2020
Section 18B.11 Public perceptions of e-cigarettes: updated April 2020
Section 5.13 Products and packaging created to appeal to new users: updated April 2020
Section 10.7 Market share and brand share in Australia: updated April 2020
Section 7.14 Cessation assistance: telephone- and internet-based interventions: updated March 2020
Section 7.15 Individual and group-based cessation assistance: updated April 2020
Section 7.1 Health and other benefits of quitting: updated March 2020
Section 7.16 Pharmacotherapies: updated March 2020
Section 9.3 Contribution of smoking to health inequality: updated March 2020
Section 3.26 Health effects of brands of tobacco which claim or imply delivery of lower levels of tar, nicotine and carbon monoxide: updated February 2020
Section 3.31 Morbidity and mortality due to tobacco-caused disease and socio-economic disadvantage: updated February 2020
Section 15.7.10 Summary of smokefree legislation across Australian states and territories: updated February 2020
Section 1.10.5 The prison population updated: February 2020
Section 9.6.6 Prison populations: updated February 2020
Section 7.19.10 Prisoners and others involved in the criminal justice system: updated February 2020
Section 5.12 Affordability of tobacco products: updated February 2020
Section 11.9.7.1 Types of licences: updated February 2020
Section 3.6 Reproductive health: updated February 2020
Section 3.7 Pregnancy and smoking: updated February 2020
Section 3.8 Child health and maternal smoking before and after birth: updated February 2020
Section 1.9 Prevalence of tobacco use among Aboriginal peoples and Torres Strait Islanders: updated February 2020
Section 16.4 Criminal cases against the tobacco industry: updated January 2020
Chapter 17 The economics of tobacco control: updated January 2020
Chapter 19 The WHO Framework Convention on Tobacco Control: updated January 2020
Section 8.3 Prevalence of tobacco use among Aboriginal peoples and Torres Strait Islanders: updated January 2020
Section 5.7 The home environment: updated December 2019
Section 7.16 Pharmacotherapies: updated December 2019
Chapter 14 Social marketing and public education campaigns: updated November 2019
Section 10.18.1 Tobacco Free Portfolios: published November 2019
Section 11.11 Tobacco advertising and promotion: Internet promotion: updated November 2019
Section 13.2 Tobacco taxes in Australia: updated November 2019
Section 9.1 Socio-economic position and disparities in tobacco exposure and use: updated November 2019
Section 9.2.4 Changes in the prevalence of smoking among students in schools in areas of varying levels of disadvantage: updated November 2019
Section 11A.6 Plain packaging—International flow-on effects: updated November 2019
Sections 9.8 Are current strategies to discourage smoking in Australia inequitable? and 9.9 Are there inequalities in access to and use of treatment for dependence on tobacco-delivered nicotine?: updated October 2019
Section 5.11 Accessibility of tobacco products to young smokers: updated October 2019
Section 7.17 Contingency management/incentives: updated October 2019
Section 13.11 Are tobacco taxes regressive?; updated September 2019
Chapter 19 The WHO Framework Convention on Tobacco Control; updated September 2019
Section 4.7 Estimates of morbidity and mortality attributable to secondhand smoke; updated September 2019
Section 5.5 Temperament, mental health problems and self-concept; updated September 2019
Section 11A.9 Real-world research on the effects of plain packaging; updated September 2019
Section 1.10.1 Prevalence of smoking in other high-risk sub-groups of the population; Smoking in pregnancy: updated August 2019
Section 8.3 Prevalence of tobacco use among Aboriginal peoples and Torres Strait Islanders: updated August 2019
Section 7.11 Smoking cessation and pregnancy: updated August 2019
Section 4.5 Prevalence of exposure to SHS in the home: updated July 2019
Chapter 5 Influences on the uptake and prevention of smoking Section 5.4 Adolescence and brain maturation; Section 5.6 Intentions, attitudes and beliefs; Section 5.9 The educational environment: updated August 2019
Section 11A.6 Plain packaging: International flow-on effects: updated July 2019
Section 15.6 Smoking bans in the home and car; Section 15.7 Legislation to ban smoking in public spaces: updated July 2019
InDepth 12A Health warnings: updated July 2019
Section 10.3 The manufacturing and wholesaling industry in Australia - major international companies: updated August 2019
Section 1.3 Prevalence of smoking—adults: updated August 2019
Section 13.3 The price of tobacco products in Australia: updated July 2019
Section 14.3 Tobacco-control campaigns in Australia: experience: updated July 2019
Section 8.13 Policies for advancing tobacco control programs among Aboriginal and Torres Strait Islander peoples: updated July 2019
Section 10.11 Corporate responsibility and the birth of good corporate citizenship: updated July 2019
Section 2.1 Production and trade data as a basis for estimating tobacco consumption: updated July 2019
Section 3.1 Smoking and heart disease: updated July 2019
Section 2.3 Self-reported measures of tobacco consumption: updated June 2019
Section 13.2 Tobacco taxes in Australia: updated June 2019
Section 3.0 Health effects: Introduction: updated June 2019
Section 3.30 Total burden of death and disease attributable to tobacco by disease category: updated June 2019
Section 3.34 Public perceptions of tobacco as a drug, and knowledge and beliefs about the health consequences of smoking: updated May 2019
Section 18B.10 Key Australian and international position statements on e-cigarettes, health, and options for regulation: updated May 2019
InDepth 18C Heated tobacco (‘heat-not-burn’) products: updated March 2019
Section 2.2 Dutiable tobacco products as an estimate of tobacco consumption: updated May 2019
Section 10.0 The tobacco industry in Australian society: Introduction; 10.2 The global tobacco manufacturing industry; 10.3 The manufacturing and wholesaling industry in Australia—major international companies; 10.4 Other importers operating in the Australian market; 10.5 Retailing of tobacco products in Australia; 10.6 Retail value and volume of the Australian tobacco market; 10.7 Market share and brand share in Australia: updated May 2019
Section 5.0 Influences on the uptake and prevention of smoking: Introduction: updated April 2019
Section 1.6 Prevalence of smoking—teenagers: updated February 2019
Section 18B.8 Electronic cigarettes (e-cigarettes): Legal status in Australia: updated March 2019
Section 5.1 Stages in the uptake of smoking; Section 5.2 Factors influencing uptake by young people: overview; and Section 5.3 Early biological factors: updated February 2019
Section 10.7 Market share and brand share in Australia: updated February 2019, including a comprehensive list of factory-made cigarettes and roll-your-own tobacco products available for sale at major Australian retailers
Section 10A.7 Mechanisms of influence—political lobbying: updated February 2019
Section 11.11 Internet promotion: updated February 2019
Section 18B.11 Electronic cigarettes (e-cigarettes): Public perceptions of e-cigarettes: updated February 2019
Section 18B.9 Electronic cigarettes (e-cigarettes): International regulatory review and Section 18B.10 Key Australian and international position statements on e-cigarettes, health, and options for regulation: updated February 2019
Section 1.3 Prevalence of smoking—adults: updated February 2019
Section 18B.7 Electronic cigarettes (e-cigarettes): Potential positive impacts: updated January 2019
Section 18B.1 Electronic cigarettes (e-cigarettes):The e-cigarette market and Section 18B.2 Advertising and promotion: updated January 2019
Section 13.2 Tobacco taxes in Australia: updated November 2018
Section 18B.5 Electronic cigarettes (e-cigarettes): Health risks of e-cigarettes and Section 18B.6 Potential negative impacts: updated November 2018
**New InDepth** 11A Packaging as promotion: Evidence for and effects of plain packaging: published November 2018
Section 9.9 Are there inequalities in access to and use of treatment for dependence on tobacco-delivered nicotine?: updated November 2018
Section 8.3 Prevalence of tobacco use among Aboriginal peoples and Torres Strait Islanders: updated October 2018
Section 7.16 Pharmacotherapies: updated October 2018
Section 18B.3 Electronic cigarettes (e-cigarettes): Extent of use and Section 18B.4 Safety and abuse potential: updated October 2018
Section 10.17 Public attitudes to the tobacco industry: updated October 2018
Section 11.4 State and territory legislation: updated September 2018
Section 11.9 Retail promotion and access: updated September 2018
Section 5.21 Reducing tobacco and supply: updated September 2018
Section 18.4 Low nicotine - nicotine reduction: updated September 2018
Chapter 19 The WHO Framework Convention on Tobacco Control: updated September 2018
Section 8.3.5 Prevalence of smoking among pregnant Aboriginal and Torres Strait Islander women: updated September 2018
Section 7.11.2 Rates of smoking during pregnancy: updated September 2018
Section 1.10.1 Smoking in pregnancy: updated September 2018
Section 15.9 Effectiveness of smokefree legislation in reducing exposure to tobacco toxins, improving health, and changing smoking behaviours: updated June 2018
Section 8.3 Prevalence of tobacco use among Aboriginal and Torres Strait Islander peoples: updated June 2018
Section 1.3 Prevalence of smoking—adults: updated June 2018
**New sections** 16.4 Criminal cases against the tobacco industry and 16.5 Legal cases initiated by tobacco industry: published May 2018
**New InDepth** InDepth 10A Tobacco industry: Strategies for influence; and Section 10.18 The investment of public funds in tobacco—the case for divestment: published May 2018
Sections 10.17 Public attitudes to the tobacco industry; and 10.19 The future of the tobacco industry: updated May 2018
Section 8.7 Morbidity and mortality caused by smoking among Aboriginal and Torres Strait Islander peoples: updated May 2018
Section 5.21 Reducing tobacco access and supply: updated May 2018
Section 13.2 Tobacco taxes in Australia: updated March 2018
Section 7.12 Smoking and mental health: updated March 2018
Section 11.10.9 Plain packaging: International flow-on effects: updated April 2018
**New chapter** InDepth 18C Heated tobacco (‘heat-not-burn’) products: published March 2018
Section 10.20 Tobacco industry intervention in political and judicial processes—political donations: updated March 2018
Chapter 6 Addiction: updated March 2018
Section 9.1 Socio-economic position and disparities in tobacco exposure and use and Section 9.2 Socio-economic disparities in tobacco exposure and use: are the gaps widening?: updated January 2018
Section 7.6 How smokers go about quitting: updated January 2018
Section 2.3 Self-reported measures of tobacco consumption: updated December 2017
Chapter 1 Prevalence (including an analysis of NDSHS data for detailed prevalence figures and trends only available in Facts & Issues): updated December 2017
Sections 10.1 The tobacco growing industry; 10.2 The global tobacco manufacturing industry; 10.3 The manufacturing and wholesaling industry in Australia—major international companies; 10.4 Other importers operating in the Australian market; 10.6 Retail value and volume of the Australian tobacco market; and 10.7 Market share and brand share in Australia: updated November 2017
New section: 10.5 Retailing of tobacco products in Australia: published November 2017
Section 3.30 Total burden of death and disease attributable to tobacco by disease category: updated November 2017
Section 10.15 Ethical issues related to farming: updated August 2017
Section 18B.2 Electronic cigarettes (e-cigarettes): Advertising and promotion and Section 18B.11 Public perceptions of e-cigarettes: updated November 2017
Section 18B.1 Electronic cigarettes (e-cigarettes): The e-cigarette market: updated October 2017
Appendix 1.4 Australian and state/territory tobacco control strategies: updated October 2017
Section 13.3 The price of tobacco products in Australia: updated September 2017
Section 10.8 Trends in products and packaging and Section 10.9 Brand portfolio strategies in the Australia market: updated September 2017
Section 18B.4 Electronic cigarettes (e-cigarettes): Safety and abuse potential and Section 18B.9 International regulatory overview: updated September 2017
Section 18B.3 Electronic cigarettes (e-cigarettes): Extent of use and Section 18B.8 Legal status: updated August 2017
Table 15.7.10 Smokefree legislation in Australian states and territories: updated July 2017
Section 10.10 Tobacco industry document repositories: updated July 2017
Section 10.12 Revised stance on health issues: updated July 2017
Section 1.11 Prevalence of use of different types of tobacco products: updated June 2017
Sections 1.4 and 1.5 Prevalence of smoking, current prevalence in adults, young adults and older adults: updated June 2017
Section 15.4 Smoking bans in key public areas and environments: updated January 2017
Section 15.6 Smoking bans in domestic environments: updated January 2017
Chapter 4 The health effects of secondhand smoke: last updated January 2017
Section 13.6 Revenue from tobacco taxes in Australia: updated December 2016
Chapter 9 Smoking and social disadvantage: last updated December 2016
Section 10.14 The environmental impact of tobacco production and Section 10.16 The environmental impact of tobacco use: last updated December 2016
A comprehensive timeline of the history of tobacco in Australia: published December 2016
New section: 11.10.13 Effects of plain packaging in Australia post-implementation: published November 2016
Chapter 7 Smoking cessation: last updated October 2016
Section 15.7 Commonwealth and state/territory legislation to ban smoking in public spaces: last updated October 2016
Commonwealth and state/territory legislation on tobacco advertising & promotion: last updated October 2016
Chapter 8 Tobacco use among Aboriginal peoples and Torres Strait Islanders: last updated September 2016
**New chapter** Chapter 18: Potential for harm reduction in tobacco control (includes e-cigarettes): published August 2016
Section 11.9 Retail promotion and access: last updated and significantly expanded April 2016
Chapter 1 Prevalence (including an analysis of NDSHS data for detailed prevalence figures and trends only available in Facts & Issues): last updated December 2015
Chapter 3 Health effects of active smoking: last updated May 2015
Links at the end of each section, where recent news and research relevant to each topic is compiled
Chapter 5 Influences on the uptake and prevention of smoking: last updated November 2014